Literature DB >> 7002232

The nature and action of granulocyte-macrophage colony stimulating factors.

A W Burgess, D Metcalf.   

Abstract

Granulocyte-macrophage colony stimulating factor (GM-CSF) stimulates the in vitro proliferation and differentiation of granulocytic and macrophage cells. This regulator is now known to act at other levels of hemopoietic regulation. The heterogeneity of GM-CSFs is not only related to the tissue of origin and the in vitro production method, but also to functional subclasses of the molecule that have distinct biologic specificities. Most adult mouse organs produce GM-CSF (mol wt 23,000), but a macrophage (M)-CSF has been detected in fetal conditioned medium (CM) and isolated from L-cell CM. Murine endotoxin serum appears to contain a M-CSF, GM-CSF, and G-CSF, the last of which cofractionates with a differentiation factor active on leukemic cells. Human GM-CSFs, G-CSF, and EO-CSFs active on human cells have been detected in a variety of CM, but as yet none have been purified. Again, there are subclasses of progenitor cells that respond to particular forms of human active CSFs. GM-CSF isolated from mouse lung CM stimulates multipotential progenitor cells, the initial proliferatin of progenitors in the erythroid, eosinophil, and megakaryocyte series, as well as mature cells in the GM series. While GM-CSF is also able to stimulate the differentiation of myeloid leukemic cells, other factors appear to be more potent in this respect. Information on the regulation of GM-CSF production, on the modulators of its action on specific target cells, and on its role in vivo will be required before the physiologic function of this molecule can be properly assessed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7002232

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  137 in total

1.  Ki-1 lymphoma with nodular involvement in liver and spleen: possible role of cytokines in systemic manifestation of fever and leukocytosis.

Authors:  Y Harada; S Yamada; S Murakami; S Mine; Y Momosaka; J Tsukada; I Morimoto; S Eto
Journal:  Dig Dis Sci       Date:  2000-11       Impact factor: 3.199

Review 2.  [New biologics and orally available compounds. What is still in the pipeline?].

Authors:  M Grünke; H Bastian; H Schulze-Koops; G-R Burmester
Journal:  Z Rheumatol       Date:  2010-09       Impact factor: 1.372

3.  Enhancement of hematopoiesis and lymphopoiesis in diet-induced obese mice.

Authors:  Mark D Trottier; Afia Naaz; Yihang Li; Pamela J Fraker
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-25       Impact factor: 11.205

Review 4.  Neutropenia in the newborn.

Authors:  Akhil Maheshwari
Journal:  Curr Opin Hematol       Date:  2014-01       Impact factor: 3.284

5.  Identification of a functional receptor for granulocyte colony-stimulating factor on platelets.

Authors:  K Shimoda; S Okamura; N Harada; S Kondo; T Okamura; Y Niho
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

6.  Therapeutic effect of granulocyte colony-stimulating factor and cephem antibiotics against experimental infections in neutropenic mice induced by cyclophosphamide.

Authors:  H Wakiyama; S Tsuru; N Hata; M Shinomiya; N Shinomiya; M Noritake; Y Umezawa; M Rokutanda
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

7.  Expression of GM-CSF in T Cells Is Increased in Multiple Sclerosis and Suppressed by IFN-β Therapy.

Authors:  Javad Rasouli; Bogoljub Ciric; Jaime Imitola; Patricia Gonnella; Daniel Hwang; Kedar Mahajan; Elisabeth R Mari; Farinaz Safavi; Thomas P Leist; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  J Immunol       Date:  2015-04-27       Impact factor: 5.422

Review 8.  Molecular regulation of dendritic cell development and function in homeostasis, inflammation, and cancer.

Authors:  Taylor T Chrisikos; Yifan Zhou; Natalie Slone; Rachel Babcock; Stephanie S Watowich; Haiyan S Li
Journal:  Mol Immunol       Date:  2018-03-15       Impact factor: 4.407

9.  Pulmonary pharmacodynamics of an anti-GM-CSFRα antibody enables therapeutic dosing that limits exposure in the lung.

Authors:  Jamie Campbell; Josquin Nys; Laura Eghobamien; E Suzanne Cohen; Matthew J Robinson; Matthew A Sleeman
Journal:  MAbs       Date:  2016-08-12       Impact factor: 5.857

10.  Multiple hemopoietic lineages are found after stimulation of mouse bone marrow precursor cells with interleukin 3.

Authors:  M B Prystowsky; G Otten; M F Naujokas; J Vardiman; J N Ihle; E Goldwasser; F W Fitch
Journal:  Am J Pathol       Date:  1984-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.